Kineret (Swedish Orphan Biovitrum AB (publ))
Welcome to the PulseAid listing for the Kineret drug offered from Swedish Orphan Biovitrum AB (publ). This Interleukin 1 Receptor Antagonists [MoA],Interleukin-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Swedish Orphan Biovitrum AB (publ) |
| NON-PROPRIETARY NAME: | anakinra |
| SUBSTANCE NAME: | ANAKINRA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Interleukin 1 Receptor Antagonists [MoA],Interleukin-1 Receptor Antagonist [EPC] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2009-12-15 |
| END MARKETING DATE: | 0000-00-00 |
Kineret HUMAN PRESCRIPTION DRUG Details:
| Item Description | Kineret from Swedish Orphan Biovitrum AB (publ) |
| LABELER NAME: | Swedish Orphan Biovitrum AB (publ) |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/.67mL) |
| START MARKETING DATE: | 2009-12-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66658-234_23568233-c1c2-4eb7-be9e-881cf32c85c5 |
| PRODUCT NDC: | 66658-234 |
| APPLICATION NUMBER: | BLA103950 |
Other ANAKINRA Pharmaceutical Manufacturers / Labelers:
